scholarly article | Q13442814 |
P356 | DOI | 10.1017/S1355617708081010 |
P698 | PubMed publication ID | 18764978 |
P50 | author | Ignasi Gich | Q50617525 |
Antonia Campolongo | Q57015573 | ||
Jaime Kulisevsky | Q64855171 | ||
Javier Pagonabarraga | Q64855172 | ||
Berta Pascual-Sedano | Q66717789 | ||
Alexandre Gironell | Q42408233 | ||
P2093 | author name string | Manel Barbanoj | |
Carmen García-Sánchez | |||
P2860 | cites work | “Mini-mental state” | Q25938989 |
An Inventory for Measuring Depression | Q26778503 | ||
High-Speed Scanning in Human Memory | Q28257618 | ||
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease | Q31027552 | ||
Dopamine supports sentence comprehension in Parkinson's Disease | Q32145067 | ||
Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. | Q33889084 | ||
Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels | Q48839986 | ||
The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease | Q48891136 | ||
Neuropsychological profile of patients with Parkinson's disease without dementia. | Q51950566 | ||
Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication. | Q52027275 | ||
Age-related cognitive deficits mediated by changes in the striatal dopamine system. | Q52028033 | ||
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. | Q52170683 | ||
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease | Q62706215 | ||
D(1) receptors in prefrontal cells and circuits | Q73553186 | ||
Nonmotor fluctuations in Parkinson's disease: frequent and disabling | Q74606841 | ||
Shared cognitive processes underlying performance on the Wisconsin Card Sorting Test and the Stroop Test in patients with schizophrenia: a measurement artifact? | Q79214181 | ||
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease | Q33985023 | ||
Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism | Q34070904 | ||
Neural bases of set-shifting deficits in Parkinson's disease. | Q34291524 | ||
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease | Q34423750 | ||
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate | Q34753882 | ||
L-dopa impairs learning, but spares generalization, in Parkinson's disease | Q35113281 | ||
What contributes to quality of life in patients with Parkinson's disease? | Q35459164 | ||
What causes mental dysfunction in Parkinson's disease? | Q35540203 | ||
Levodopa in the treatment of Parkinson's disease: current controversies | Q35889917 | ||
Molecular imaging of the dopaminergic system and its association with human cognitive function | Q36472025 | ||
Cognitive function in Parkinson's disease: From description to theory | Q36555846 | ||
Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa? | Q36587747 | ||
Insights into the role of dopamine receptor systems in learning and memory | Q36778973 | ||
Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats | Q36969324 | ||
Basal ganglia dysfunction, working memory, and sentence comprehension in patients with Parkinson's disease | Q38438683 | ||
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up | Q39216879 | ||
Clinical applications of visual analogue scales: a critical review. | Q39583550 | ||
Issues associated with repeated neuropsychological assessments | Q40973194 | ||
The response to levodopa in Parkinson's disease: imposing pharmacological law and order | Q40981288 | ||
Pathogenesis of dyskinesias in Parkinson's disease | Q41233549 | ||
'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa | Q41437567 | ||
Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow | Q41476240 | ||
Dopaminergic modulation of cortical function in patients with Parkinson's disease | Q42163888 | ||
Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease | Q42603205 | ||
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction | Q43643543 | ||
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands | Q43800068 | ||
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. | Q43901509 | ||
A model of prefrontal cortex dopaminergic modulation during the delayed alternation task | Q44111114 | ||
Dopaminergic modulation of visual-spatial working memory in Parkinson's disease | Q44302201 | ||
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease | Q44505615 | ||
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias | Q45030408 | ||
By carrot or by stick: cognitive reinforcement learning in parkinsonism | Q45140702 | ||
Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS-R NI. | Q46308362 | ||
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications | Q48088787 | ||
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease | Q48147372 | ||
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction | Q48176523 | ||
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory | Q48285410 | ||
Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction | Q48320111 | ||
The neural correlates and functional integration of cognitive control in a Stroop task | Q48505681 | ||
Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study | Q48508628 | ||
High-speed memory scanning in Parkinson's disease: adverse effects of levodopa | Q48713181 | ||
Cognitive deficits in the early stages of Parkinson's disease | Q48800336 | ||
P433 | issue | 5 | |
P921 | main subject | Parkinson's disease | Q11085 |
levodopa | Q300989 | ||
P304 | page(s) | 832-841 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Journal of the International Neuropsychological Society | Q15755321 |
P1476 | title | Levodopa and executive performance in Parkinson's disease: a randomized study. | |
P478 | volume | 14 |
Q40099576 | A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult with Parkinson's Disease. |
Q38156172 | Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review |
Q44784228 | Apathy in Parkinson's disease: more than just executive dysfunction |
Q37968511 | Cognitive impairment in nondemented Parkinson's disease |
Q42515523 | Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease |
Q43285160 | Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances |
Q21090466 | Executive dysfunction in Parkinson's disease and timing deficits |
Q38134409 | Executive dysfunction in Parkinson's disease: a review |
Q48275756 | Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders |
Q37141684 | Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease |
Q38805976 | Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease |
Q38111335 | Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease |
Q39601396 | Startle Habituation and Midfrontal Theta Activity in Parkinson Disease. |
Q27021220 | Mild cognitive impairment in Parkinson's disease. |
Search more.